{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:19:04Z","timestamp":1782922744507,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T00:00:00Z","timestamp":1518998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004504","name":"Lietuvos Mokslo Taryba","doi-asserted-by":"publisher","award":["MIP-044\/2015"],"award-info":[{"award-number":["MIP-044\/2015"]}],"id":[{"id":"10.13039\/501100004504","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s11060-018-2803-y","type":"journal-article","created":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T00:57:19Z","timestamp":1519001839000},"page":"351-358","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Prognostic role of high sensitivity C-reactive protein and interleukin-6 in glioma and meningioma patients"],"prefix":"10.1007","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0446-6898","authenticated-orcid":false,"given":"Adomas","family":"Bunevicius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrius","family":"Radziunas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarunas","family":"Tamasauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arimantas","family":"Tamasauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwards R.","family":"Laws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Iervasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robertas","family":"Bunevicius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vytenis","family":"Deltuva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,19]]},"reference":[{"issue":"suppl_5","key":"2803_CR1","doi-asserted-by":"publisher","first-page":"v1v75","DOI":"10.1093\/neuonc\/now207","volume":"18","author":"QT Ostrom","year":"2016","unstructured":"Ostrom QT, Gittleman H, Xu J et al (2016) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009\u20132013. Neuro Oncol 18(suppl_5):v1\u2013v75. \n                    https:\/\/doi.org\/10.1093\/neuonc\/now207","journal-title":"Neuro Oncol"},{"key":"2803_CR2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.clineuro.2016.05.002","volume":"146","author":"T Wegman-Ostrosky","year":"2016","unstructured":"Wegman-Ostrosky T, Reynoso-Nover\u00f3n N, Mej\u00eda-P\u00e9rez SI et al (2016) Clinical prognostic factors in adults with astrocytoma: Historic cohort. Clin Neurol Neurosurg 146:116\u2013122. \n                    https:\/\/doi.org\/10.1016\/j.clineuro.2016.05.002","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"2803_CR3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3171\/2008.4.17536","volume":"110","author":"MJ McGirt","year":"2009","unstructured":"McGirt MJ, Chaichana KL, Gathinji M et al (2009) Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg 110(1):156\u2013162. \n                    https:\/\/doi.org\/10.3171\/2008.4.17536","journal-title":"J Neurosurg"},{"issue":"5","key":"2803_CR4","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3109\/02688697.2015.1054348","volume":"29","author":"S Mukherjee","year":"2015","unstructured":"Mukherjee S, Thakur B, Corns R et al (2015) Resection of olfactory groove meningioma - a review of complications and prognostic factors. Br J Neurosurg 29(5):685\u2013692. \n                    https:\/\/doi.org\/10.3109\/02688697.2015.1054348","journal-title":"Br J Neurosurg"},{"issue":"5","key":"2803_CR5","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1093\/neuonc\/nos013","volume":"14","author":"H Alkemade van","year":"2012","unstructured":"van Alkemade H, de Leau M, Dieleman EMT et al (2012) Impaired survival and long-term neurological problems in benign meningioma. Neuro Oncol 14(5):658\u2013666. \n                    https:\/\/doi.org\/10.1093\/neuonc\/nos013","journal-title":"Neuro Oncol"},{"issue":"2","key":"2803_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.cyto.2014.09.008","volume":"71","author":"A Christofides","year":"2015","unstructured":"Christofides A, Kosmopoulos M, Piperi C (2015) Pathophysiological mechanisms regulated by cytokines in gliomas. Cytokine 71(2):377\u2013384. \n                    https:\/\/doi.org\/10.1016\/j.cyto.2014.09.008","journal-title":"Cytokine"},{"issue":"5","key":"2803_CR7","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/labinvest.2017.19","volume":"97","author":"A Gieryng","year":"2017","unstructured":"Gieryng A, Pszczolkowska D, Walentynowicz KA, Rajan WD, Kaminska B (2017) Immune microenvironment of gliomas. Lab Investig 97(5):498\u2013518. \n                    https:\/\/doi.org\/10.1038\/labinvest.2017.19","journal-title":"Lab Investig"},{"issue":"5","key":"2803_CR8","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","volume":"1813","author":"J Scheller","year":"2011","unstructured":"Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S (2011) The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 1813(5):878\u2013888. \n                    https:\/\/doi.org\/10.1016\/j.bbamcr.2011.01.034","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"2803_CR9","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jocn.2004.11.017","volume":"12","author":"C-Y Chang","year":"2005","unstructured":"Chang C-Y, Li M-C, Liao S-L, Huang Y-L, Shen C-C, Pan H-C (2005) Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme. J Clin Neurosci 12(8):930\u2013933. \n                    https:\/\/doi.org\/10.1016\/j.jocn.2004.11.017","journal-title":"J Clin Neurosci"},{"issue":"3","key":"2803_CR10","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3171\/jns.1994.81.3.0394","volume":"81","author":"T Todo","year":"1994","unstructured":"Todo T, Adams EF, Rafferty B, Fahlbusch R, Dingermann T, Werner H (1994) Secretion of interleukin-6 by human meningioma cells: possible autocrine inhibitory regulation of neoplastic cell growth. J Neurosurg 81(3):394\u2013401. \n                    https:\/\/doi.org\/10.3171\/jns.1994.81.3.0394","journal-title":"J Neurosurg"},{"issue":"4","key":"2803_CR11","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/(SICI)1096-9896(199712)183:4<460::AID-PATH961>3.0.CO;2-Z","volume":"183","author":"TH Jones","year":"1997","unstructured":"Jones TH, Justice SK, Timperley WR, Royds JA (1997) Effects of interleukin-1 and dexamethasone on interleukin-6 production and growth in human meningiomas. J Pathol 183(4):460\u2013468","journal-title":"J Pathol"},{"issue":"1","key":"2803_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3171\/2009.4.JNS09158","volume":"112","author":"K-J Park","year":"2010","unstructured":"Park K-J, Kang S-H, Chae Y-S et al (2010) Influence of interleukin-6 on the development of peritumoral brain edema in meningiomas. J Neurosurg 112(1):73\u201380. \n                    https:\/\/doi.org\/10.3171\/2009.4.JNS09158","journal-title":"J Neurosurg"},{"issue":"2","key":"2803_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/0167-5699(94)90137-6","volume":"15","author":"H Baumann","year":"1994","unstructured":"Baumann H, Gauldie J (1994) The acute phase response. Immunol Today 15(2):74\u201380. \n                    https:\/\/doi.org\/10.1016\/0167-5699(94)90137-6","journal-title":"Immunol Today"},{"issue":"6","key":"2803_CR14","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.ahj.2015.09.018","volume":"170","author":"J Aulin","year":"2015","unstructured":"Aulin J, Siegbahn A, Hijazi Z et al (2015) Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation. Am Heart J 170(6):1151\u20131160. \n                    https:\/\/doi.org\/10.1016\/j.ahj.2015.09.018","journal-title":"Am Heart J"},{"issue":"1","key":"2803_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ijcard.2006.09.004","volume":"120","author":"A Hedman","year":"2007","unstructured":"Hedman A, Larsson PT, Alam M, Wallen NH, Nordlander R, Samad BA. CRP (2007) IL-6 and endothelin-1 levels in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early graft occlusion and late cardiovascular events? Int J Cardiol 120(1):108\u2013114. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2006.09.004","journal-title":"Int J Cardiol"},{"issue":"8","key":"2803_CR16","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3109\/0284186X.2013.835494","volume":"52","author":"C Kersten","year":"2013","unstructured":"Kersten C, Louhimo J, \u00c5lgars A et al (2013) Increased C-reactive protein implies a poorer stage-specific prognosis in colon cancer. Acta Oncol 52(8):1691\u20131698. \n                    https:\/\/doi.org\/10.3109\/0284186X.2013.835494","journal-title":"Acta Oncol"},{"key":"2803_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fneur.2016.00189","volume":"7","author":"F Licastro","year":"2016","unstructured":"Licastro F, Hrelia S, Porcellini E et al (2016) Peripheral Inflammatory markers and antioxidant response during the post-acute and chronic phase after severe traumatic brain injury. Front Neurol 7:189. \n                    https:\/\/doi.org\/10.3389\/fneur.2016.00189","journal-title":"Front Neurol"},{"issue":"8","key":"2803_CR18","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.05.005","volume":"24","author":"G Pusch","year":"2015","unstructured":"Pusch G, Debrabant B, Molnar T et al (2015) Early dynamics of P-selectin and interleukin 6 predicts outcomes in ischemic stroke. J Stroke Cerebrovasc Dis 24(8):1938\u20131947. \n                    https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2015.05.005","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"12","key":"2803_CR19","doi-asserted-by":"publisher","first-page":"CC08-11","DOI":"10.7860\/JCDR\/2014\/10386.5302","volume":"8","author":"D Patgiri","year":"2014","unstructured":"Patgiri D, Pathak MS, Sharma P, Kutum T, Mattack N (2014) Serum hsCRP: a novel marker for prediction of cerebrovascular accidents (stroke). J Clin Diagn Res 8(12):CC08-11. \n                    https:\/\/doi.org\/10.7860\/JCDR\/2014\/10386.5302","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"2803_CR20","first-page":"339","volume":"34","author":"T Strojnik","year":"2014","unstructured":"Strojnik T, Smigoc T, Lah TT (2014) Prognostic value of erythrocyte sedimentation rate and C-reactive protein in the blood of patients with glioma. Anticancer Res 34(1):339\u2013347","journal-title":"Anticancer Res"},{"issue":"1","key":"2803_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11060-010-0290-x","volume":"102","author":"G Reyn\u00e9s","year":"2011","unstructured":"Reyn\u00e9s G, Vila V, Mart\u00edn M et al (2011) Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma. J Neurooncol 102(1):35\u201341. \n                    https:\/\/doi.org\/10.1007\/s11060-010-0290-x","journal-title":"J Neurooncol"},{"key":"2803_CR22","unstructured":"Jennett B, Bond M (1975) Assessment of outcome after severe brain damage. Lancet (London, England) 1(7905):480\u2013484. \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/46957\n                    \n                  . Accessed 4 Sept 2017"},{"issue":"6","key":"2803_CR23","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3171\/2013.1.JNS121696","volume":"118","author":"A Bunevicius","year":"2013","unstructured":"Bunevicius A, Deltuva V, Tamasauskas S, Tamasauskas A, Laws ER, Bunevicius R (2013) Low triiodothyronine syndrome as a predictor of poor outcomes in patients undergoing brain tumor surgery: a pilot study: clinical article. J Neurosurg 118(6):1279\u20131287. \n                    https:\/\/doi.org\/10.3171\/2013.1.JNS121696","journal-title":"J Neurosurg"},{"issue":"4","key":"2803_CR24","first-page":"276","volume":"17","author":"J I\u0142zecka","year":"2006","unstructured":"I\u0142zecka J, I\u0142zecki M (2006) APRIL is increased in serum of patients with brain glioblastoma multiforme. Eur Cytokine Netw 17(4):276\u2013280","journal-title":"Eur Cytokine Netw"},{"issue":"9","key":"2803_CR25","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.7314\/APJCP.2013.14.9.5225","volume":"14","author":"M Doroudchi","year":"2013","unstructured":"Doroudchi M, Pishe ZG, Malekzadeh M, Golmoghaddam H, Taghipour M, Ghaderi A (2013) Elevated serum IL-17A but not IL-6 in glioma versus meningioma and schwannoma. Asian Pac J Cancer Prev 14(9):5225\u20135230","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"2803_CR26","first-page":"9","volume":"58","author":"A Kataki","year":"2014","unstructured":"Kataki A, Skandami V, Memos N et al (2014) Similar immunity profiles in patients with meningioma and glioma tumors despite differences in the apoptosis and necrosis of circulating lymphocyte and monocyte populations. J Neurosurg Sci 58(1):9\u201315","journal-title":"J Neurosurg Sci"},{"issue":"4","key":"2803_CR27","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.intimp.2012.08.007","volume":"14","author":"U Demirci","year":"2012","unstructured":"Demirci U, Yaman M, Buyukberber S et al (2012) Prognostic importance of markers for inflammation, angiogenesis and apoptosis in high grade glial tumors during temozolomide and radiotherapy. Int Immunopharmacol 14(4):546\u2013549. \n                    https:\/\/doi.org\/10.1016\/j.intimp.2012.08.007","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"2803_CR28","first-page":"1513","volume":"15","author":"R Kumar","year":"2006","unstructured":"Kumar R, Kamdar D, Madden L et al (2006) Th1\/Th2 cytokine imbalance in meningioma, anaplastic astrocytoma and glioblastoma multiforme patients. Oncol Rep 15(6):1513\u20131516","journal-title":"Oncol Rep"},{"issue":"7","key":"2803_CR29","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jocn.2007.06.001","volume":"15","author":"JR Vignes","year":"2008","unstructured":"Vignes JR, Sesay M, Rezajooi K, Gimbert E, Liguoro D (2008) Peritumoral edema and prognosis in intracranial meningioma surgery. J Clin Neurosci 15(7):764\u2013768. \n                    https:\/\/doi.org\/10.1016\/j.jocn.2007.06.001","journal-title":"J Clin Neurosci"},{"issue":"7","key":"2803_CR30","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/j.1468-1331.2009.02613.x","volume":"16","author":"K Schoenegger","year":"2009","unstructured":"Schoenegger K, Oberndorfer S, Wuschitz B et al (2009) Peritumoral edema on MRI at initial diagnosis: an independent prognostic factor for glioblastoma? Eur J Neurol 16(7):874\u2013878. \n                    https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02613.x","journal-title":"Eur J Neurol"},{"issue":"6","key":"2803_CR31","first-page":"9114","volume":"8","author":"Y Shan","year":"2015","unstructured":"Shan Y, He X, Song W, Han D, Niu J, Wang J (2015) Role of IL-6 in the invasiveness and prognosis of glioma. Int J Clin Exp Med 8(6):9114\u20139120","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"2803_CR32","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/sj.bjc.6603586","volume":"96","author":"A Tchirkov","year":"2007","unstructured":"Tchirkov A, Khalil T, Chautard E et al (2007) Interleukin-6 gene amplification and shortened survival in glioblastoma patients. Br J Cancer 96(3):474\u2013476. \n                    https:\/\/doi.org\/10.1038\/sj.bjc.6603586","journal-title":"Br J Cancer"},{"issue":"10","key":"2803_CR33","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1002\/stem.188","volume":"27","author":"H Wang","year":"2009","unstructured":"Wang H, Lathia JD, Wu Q et al (2009) Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth. Stem Cells 27(10):2393\u20132404. \n                    https:\/\/doi.org\/10.1002\/stem.188","journal-title":"Stem Cells"},{"issue":"6","key":"2803_CR34","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S1474-4422(05)70099-5","volume":"4","author":"H-K Kuo","year":"2005","unstructured":"Kuo H-K, Yen C-J, Chang C-H, Kuo C-K, Chen J-H, Sorond F (2005) Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol 4(6):371\u2013380. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(05)70099-5","journal-title":"Lancet Neurol"},{"issue":"9709","key":"2803_CR35","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","volume":"375","author":"S Kaptoge","year":"2010","unstructured":"Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, et al (2010) C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375(9709):132\u2013140. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(09)61717-7","journal-title":"Lancet"},{"issue":"6","key":"2803_CR36","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1159\/000381218","volume":"22","author":"A Bunevicius","year":"2015","unstructured":"Bunevicius A, Kazlauskas H, Raskauskiene N et al (2015) Role of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and inteleukin-6 in predicting a poor outcome after a stroke. Neuroimmunomodulation 22(6):365\u2013372. \n                    https:\/\/doi.org\/10.1159\/000381218","journal-title":"Neuroimmunomodulation"},{"issue":"1","key":"2803_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1001\/archneurol.2009.308","volume":"67","author":"JM Noble","year":"2010","unstructured":"Noble JM, Manly JJ, Schupf N, Tang MX, Mayeux R, Luchsinger JA (2010) Association of C-reactive protein with cognitive impairment. Arch Neurol 67(1):87\u201392. \n                    https:\/\/doi.org\/10.1001\/archneurol.2009.308","journal-title":"Arch Neurol"},{"issue":"34","key":"2803_CR38","doi-asserted-by":"publisher","first-page":"57543","DOI":"10.18632\/oncotarget.15743","volume":"8","author":"A Bunevicius","year":"2017","unstructured":"Bunevicius A, Deltuva VP, Tamasauskas A (2017) Association of pre-operative depressive and anxiety symptoms with five-year survival of glioma and meningioma patients: a prospective cohort study. Oncotarget 8(34):57543\u201357551. \n                    https:\/\/doi.org\/10.18632\/oncotarget.15743","journal-title":"Oncotarget"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-018-2803-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-018-2803-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-018-2803-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T19:55:45Z","timestamp":1550519745000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-018-2803-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,19]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["2803"],"URL":"https:\/\/doi.org\/10.1007\/s11060-018-2803-y","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,19]]},"assertion":[{"value":"29 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}